Ocugen Inc. Announces Plan to Postpone Annual Meeting of Stockholders

Stock Information for Ocugen, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ocugen, Inc.

OCGN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if You Lost Money on Your Ocugen, Inc. investment
Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial - First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ocugen, Inc. - OCGN
Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410-a Modifier Gene Therapy-in Phase 1/2 ArMaDa Study for Geographic Atrophy
Ocugen, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Ocugen (OCGN)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ocugen, Inc. - OCGN
Ocugen, Inc. (OCGN) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
ATTENTION Ocugen, Inc. Investors: You May Have Been Affected by Fraud - Contact Levi & Korsinsky to Discuss Your Rights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.